Evidence map›Paper›PMID 31320940›Full record

ArticleNanobiomedicine

Halloysite nanotubes as a nature's boon for biomedical applications.

Swathi Satish, Maithri Tharmavaram, Deepak Rawtani

Open access · hybridAbstract read
In one paragraph

Article in Nanobiomedicine. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 31 papers.

0numbers the graph read from it
0cells of the map it votes in
31citing papers in PubMed
7.4field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

31 citing papers in PubMed, 137 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Review
  6. Article
  7. Article
  8. Functionalized Halloysite Nanotubes as Potential Drug Carriers.Journal of functional biomaterials · 2023
    Article
  9. Halloysite Nanotubes and Sepiolite for Health Applications.International journal of molecular sciences · 2023
    Review
  10. Review
  11. Article
  12. Article
  13. Review
  14. Article
  15. Review
  16. The emergence of nanoporous materials in lung cancer therapy.Science and technology of advanced materials · 2022
    Review
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

Swathi SatishInstitute of Research & Development, Gujarat Forensic Sciences University, Gandhinagar, Gujarat, India.
Maithri TharmavaramInstitute of Research & Development, Gujarat Forensic Sciences University, Gandhinagar, Gujarat, India.
Deepak RawtaniInstitute of Research & Development, Gujarat Forensic Sciences University, Gandhinagar, Gujarat, India.ORCID https://orcid.org/0000-0002-8982-2240
National Forensic Sciences University · IN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The arena of biomedical science has long been in quest of innovative mediums for diagnostic and therapeutic applications. The latest being the use of nanomaterials for such applications, thereby giving rise to the branch of nanomedicine. Halloysite nanotubes (HNTs) are naturally occurring tubular clay nanomaterials, made of aluminosilicate kaolin sheets rolled several times. The aluminol and siloxane groups on the surface of HNT facilitate the formation of hydrogen bonding with the biomaterials onto its surface. These properties render HNT pivotal in diverse range of applications, such as in environmental sciences, waste-water treatment, dye removal, nanoelectronics and fabrication of nanocomposites, catalytic studies, as glass coatings or anticorrosive coatings, in cosmetics, as flame retardants, stimuli response, and forensic sciences. The specific properties of HNT also lead to numerous applications in biomedicine and nanomedicine, namely drug delivery, gene delivery, tissue engineering, cancer and stem cells isolation, and bioimaging. In this review, recent developments in the use of HNT for various nanomedicinal applications have been discussed.

Indexed as

cancer therapydrug deliveryHalloysite nanotubenanobiomedicinetissue engineering

Identifiers

PMID31320940
PMCPMC6628522
OpenAlexW2961242023

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.